Managed Access Program to Provide Alpelisib for Patients With HR+ Advanced or Metastatic Breast Cancer
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS
Conditions: HR+ Advanced or Metastatic Breast Cancer
Interventions: DRUG: alpelisib
Sponsor: Novartis Pharmaceuticals